These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 8648033)

  • 1. Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
    Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA
    J Allergy Clin Immunol; 1996 Jun; 97(6):1356-65. PubMed ID: 8648033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in IL-8, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation.
    KleinJan A; Dijkstra MD; Boks SS; Severijnen LA; Mulder PG; Fokkens WJ
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):441-50. PubMed ID: 10069878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.
    Wachholz PA; Nouri-Aria KT; Wilson DR; Walker SM; Verhoef A; Till SJ; Durham SR
    Immunology; 2002 Jan; 105(1):56-62. PubMed ID: 11849315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
    Varney VA; Hamid QA; Gaga M; Ying S; Jacobson M; Frew AJ; Kay AB; Durham SR
    J Clin Invest; 1993 Aug; 92(2):644-51. PubMed ID: 8349803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.
    Wilson DR; Irani AM; Walker SM; Jacobson MR; Mackay IS; Schwartz LB; Durham SR
    Clin Exp Allergy; 2001 Nov; 31(11):1705-13. PubMed ID: 11696046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.
    Hamid QA; Schotman E; Jacobson MR; Walker SM; Durham SR
    J Allergy Clin Immunol; 1997 Feb; 99(2):254-60. PubMed ID: 9042055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical efficacy of grass-pollen immunotherapy.
    Durham SR; Walker SM; Varga EM; Jacobson MR; O'Brien F; Noble W; Till SJ; Hamid QA; Nouri-Aria KT
    N Engl J Med; 1999 Aug; 341(7):468-75. PubMed ID: 10441602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.
    Nouri-Aria KT; Wachholz PA; Francis JN; Jacobson MR; Walker SM; Wilcock LK; Staple SQ; Aalberse RC; Till SJ; Durham SR
    J Immunol; 2004 Mar; 172(5):3252-9. PubMed ID: 14978133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector cell signature in peripheral blood following nasal allergen challenge in grass pollen allergic individuals.
    Shamji MH; Bellido V; Scadding GW; Layhadi JA; Cheung DK; Calderon MA; Asare A; Gao Z; Turka LA; Tchao N; Togias A; Phippard D; Durham SR
    Allergy; 2015 Feb; 70(2):171-9. PubMed ID: 25377909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
    Bonvalet M; Moussu H; Wambre E; Ricarte C; Horiot S; Rimaniol AC; Kwok WW; Horak F; de Beaumont O; Baron-Bodo V; Moingeon P
    Clin Exp Allergy; 2012 Dec; 42(12):1745-55. PubMed ID: 23181790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
    Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
    Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge.
    Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR
    Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial.
    Caffarelli C; Sensi LG; Marcucci F; Cavagni G
    Allergy; 2000 Dec; 55(12):1142-7. PubMed ID: 11117271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
    Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen induced mRNA expression of interleukin-5, but not of interleukin-4 and interferon-gamma, in peripheral blood mononuclear cells obtained before the pollen season predicts the clinical efficacy of immunotherapy for seasonal allergic rhinitis.
    Kakinoki Y; Ohashi Y; Nakai Y; Washio Y; Nasako Y; Tanaka A; Nakai Y
    Scand J Immunol; 2000 Feb; 51(2):202-8. PubMed ID: 10652165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive treatment of intranasal fluticasone propionate reduces cytokine mRNA expressing cells before and during a single nasal allergen provocation.
    Kleinjan A; Holm AF; Dijkstra MD; Boks SS; Severijnen L; Mulder PG; Fokkens WJ
    Clin Exp Allergy; 2000 Oct; 30(10):1476-85. PubMed ID: 10998026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.